Drug Trial Radar · NCT05260385
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
Last checked: Nov 19, 2026Latest source record: Oct 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
133
Planned (sponsor's estimate)
Start
Jan 24, 2022
Primary completion
Oct 30, 2025
Study completion Dec 30, 2025
Sponsor
- Lead sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the preliminary efficacy, safety, tolerability and pharmacokinetics of KC1036 in participants with advanced recurrent or metastatic digestive system tumors.
Conditions
- Digestive System Tumors
Interventions
KC1036Drug
KC1036 are administered orally QD or BID in 21-day cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: approximately 2 year.
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China · Recruiting
The first affiliated hospital of bengbu medical college
Bengbu, China · Recruiting
Chongqing University Three Gorges Hospital
Chongqing, China · Recruiting
Fujian Cancer Hospital
Fujian, China · Recruiting
Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University
Henan, China · Recruiting
The First Affiliated Hospital of Xinxiang Medical University
Henan, China · Recruiting
Hubei Cancer Hospital
Hubei, China · Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technologe
Hubei, China · Recruiting
Shandong Cancer Hospital & Institute
Shandong, China · Recruiting
Shanghai Chest Hospital
Shanghai, China · Recruiting
Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center
Shenzhen, China · Recruiting
Tianjin Medical University Cancer Institute &Hospital
Tianjin, China · Recruiting
The Second Affiliated Hospital Zhejiang University School of Medicine
Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.